Up-regulation of β-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 51, 2005, Pages 18431-18436

  Jang, Kyung Lib ^a,b   Shackelford, Julia ^a   Seo, So Young ^b   Pagano, Joseph S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Pusan National University   (South Korea)

Author keywords

B lymphoma; Epstein Barr virus; Latent membrane protein 1; Ubiquitin proteasomal degradation

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; LATENT MEMBRANE PROTEIN 1; ONCOPROTEIN; PROTEASOME; PROTEIN ABSENTIA HOMOLOG 1; RNA; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE CONTROL; HUMAN; HUMAN CELL; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; VIRUS ONCOGENE;

BETA CATENIN; CELL LINE; GLYCOGEN SYNTHASE KINASE 3; LYMPHOMA, B-CELL; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PROTEIN BINDING; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 29444460384     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0504054102     Document Type: Article

References (38)

1. Gottardi, C. J. & Gumbiner, B. M. (2001) Curr. Biol. 11, R792-R794.
2. Peifer, M. & Polakis, P. (2000) Science 287, 1606-1609.
3. Gottardi, C. J. & Gumbiner, B. M. (2004) J. Cell Biol. 167, 339-349.
4. Nelson, W. J. & Nusse, R. (2004) Science 303, 1483-1487.
5. Polakis, P. (2002) Curr. Biol. 12, R499-R501.
6. Kikuchi, A. (2000) Biochem. Biophys. Res. Commun. 268, 243-248.
7. Meijer, L., Flajolet, M. & Greengard, P. (2004) Trends Pharmacol. Sci. 25, 471-480.
8. Liu, J., Stevens, J., Rote, C. A., Yost, H. J., Hu, Y., Neufeld, K. L., White, R. L. & Matsunami, N. (2001) Mol. Cell 7, 927-936.
9. Matsuzawa, S. I. & Reed, J. C. (2001) Mol. Cell 7, 915-926.
10. Hu, G. & Fearon, E. R. (1999) Mol. Cell. Biol. 19, 724-732.
11. House, C. M., Frew, I. J., Huang, H.-L., Wiche, G., Traficante, N., Nice, E., Catimel, B. & Bowtell, D. D. L. (2003) Proc. Natl. Acad. Sci. USA 100, 3101-3106.
12. Fanelli, M., Fantozzi, A., De Luca, P., Caprodossi, S., Matsuzawa, S., Lazar, M. A., Pelicci, P. G. & Minucci, S. (2004) J. Biol. Chem. 279, 5374-5379.
13. Rickinson, A. & Kieff, E. (2001) in Virology, eds. Fields, B. N., Knipe, D. M. & Howley, P. M. (Lippincott-Raven, Philadelphia).
14. Yoshizaki, T., Wakisaka, N. & Pagano, J. (2005) in Epstein-Barr Virus: Infection, Pathogenesis, and Control, ed. Robertson, E. (Horizon, Norfolk, U.K.).
15. Shackelford, J. & Pagano, J. S. (2004) Mol. Cell. Biol. 24, 5089-5093.
16. Pagano, J. S., Blaser, M., Buendia, M. A., Damania, B., Khalili, K., Raab-Traub, N. & Roizman, B. (2004) Semin. Cancer Biol. 14, 453-471.
17. Shackelford, J. & Pagano, J. S. (2005) in The Ubiquitin-Proteasome System, eds. Mayer, J., Layfield, R. (Portland, London), Vol. 41.
18. Zhang, L., Wu, L., Hong, K. & Pagano, J. S. (2001) J. Virol. 75, 12393-12401.
19. Ben-Bassat, H., Goldblum, N., Mitrani, S., Goldblum, T., Yoffey, J. M., Cohen, M. M., Bentwich, Z., Ramot, B., Klein, E. & Klein, G. (1977) Int. J. Cancer 19, 27-33.
20. Shackelford, J., Maier, C. & Pagano, J. S. (2003) Proc. Natl. Acad. Sci. USA 100, 15572-15576.
21. Calender, A., Billaud, M., Aubry, J.-P., Banchereau, J., Vuillaume, M. & Lenoir, G. M. (1987) Proc. Nad. Acad. Sci. USA 84, 8060-8064.
22. Everly, D. N., Jr., Kusano, S. & Raab-Traub, N. (2004) J. Virol. 78, 11648-11655.
23. van de Wetering, M., Oosterwegel, M., Dooijes, D. & Clevers, H. (1991) EMBO J. 10, 123-132.
24. Ciechanover, A. & Ben-Saadon, R. (2004) Trends Cell Biol. 14, 103-106.
25. Polakis, P. (2000) Genes Dev. 14, 1837-1851.
26. van Noort, M., Meeldijk, J., van der Zee, R., Destree, O. & Clevers, H. (2002) J. Biol. Chem. 277, 17901-17905.
27. Ciechanover, A. & Schwartz, A. L. (2004) Biochim. Biophys. Acta 1695, 3-17.
28. Ciechanover, A. (2003) Biochem. Soc. Trans. 31, 474-481.
29. Morrison, J. A., Klingelhutz, A. J. & Raab-Traub, N. (2003) J. Virol. 77, 12276-12284.
30. Morrison, J. A. & Raab-Traub, N. (2005) J. Virol. 79, 2375-2382.
31. Sharma, C., Pradeep, A., Wong, L., Rana, A. & Rana, B. (2004)J. Biol. Chem. 279, 35583-35594.
32. Kim, C. J., Cho, Y. G., Park, C. H., Jeong, S. W., Nam, S. W., Kim, S. Y., Lee, S. H., Yoo, N. J., Lee, J. Y. & Park, W. S. (2004) Oncogene 23, 8591-8596.
33. Topol, L., Jiang, X., Choi, H., Garrett-Beal, L., Carolan, P. J. & Yang, Y. (2003) J. Cell Biol. 162, 899-908.
34. Lu, Z. & Hunter, T. (2004) Cell Cycle 3, 571-573.
35. Xiao, J. H., Ghosn, C., Hinchman, C., Forbes, C., Wang, J., Snider, N., Cordrey, A., Zhao, Y. & Chandraratna, R. A. (2003) J. Biol. Chem. 278, 29954-29962.
36. Bonvini, P., Hwang, S. G., El-Gamil, M., Robbins, P., Kim, J. S., Trepel, J. & Neckers, L. (2000) Biochim. Biophys. Acta 1495, 308-318.
37. Cagatay, T. & Ozturk, M. (2002) Oncogene 21, 7971-7980.
38. Fiucci, G., Beaucourt, S., Duf laut, D., Lespagnol, A., Stumptner-Cuvelette, P., Geant, A., Buchwalter, G., Tuynder, M., Susini, L., Lassalle, J. M., et al. (2004) Proc. Natl. Acad. Sci. USA 101, 3510-3515.